Less than two years after CMB trainer Jacques Galipeau was hired to start the Program for Advanced Cell Therapy at the School of Medicine, PACT has obtained an FDA Investigational New Drug (IND) permit to test a treatment for complications of bone marrow transplant. Read the story from UW News.